Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma
A Phase 1 Multicenter Study of KITE-585, an Autologous Anti-BCMA CAR T-Cell Therapy, in Subjects With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma
A Phase 1 Multicenter Study of KITE-585, an Autologous Anti-BCMA CAR T-Cell Therapy, in Subjects With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma
A Phase 1 Multicenter Study of KITE-585, an Autologous Anti-BCMA CAR T-Cell Therapy, in Subjects With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma
A Phase 1 Multicenter Study of KITE-585, an Autologous Anti-BCMA CAR T-Cell Therapy, in Subjects With Relapsed/Refractory Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
CART-19 Post-ASCT for Multiple Myeloma
Phase 2 Study Of Autologous T Cells Engineered To Express an Anti-CD19 Chimeric Antigen Receptor (CART-19) Following First-line Autologous Stem Cell Transplantation for High-risk Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
CART-19 Post-ASCT for Multiple Myeloma
Phase 2 Study Of Autologous T Cells Engineered To Express an Anti-CD19 Chimeric Antigen Receptor (CART-19) Following First-line Autologous Stem Cell Transplantation for High-risk Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Joint Health Study
Joint Health Study
Status: Enrolling
Updated:  12/31/1969
Orthopaedic Institute for Children at University of California Los Angeles
mi
from
Los Angeles, CA
Joint Health Study
Joint Health Study
Status: Enrolling
Updated: 12/31/1969
Orthopaedic Institute for Children at University of California Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Joint Health Study
Joint Health Study
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Joint Health Study
Joint Health Study
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Joint Health Study
Joint Health Study
Status: Enrolling
Updated:  12/31/1969
Tulane University
mi
from
New Orleans, LA
Joint Health Study
Joint Health Study
Status: Enrolling
Updated: 12/31/1969
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Joint Health Study
Joint Health Study
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Joint Health Study
Joint Health Study
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Joint Health Study
Joint Health Study
Status: Enrolling
Updated:  12/31/1969
Washington Center for Bleeding Disorders at Bloodworks Northwest
mi
from
Seattle, WA
Joint Health Study
Joint Health Study
Status: Enrolling
Updated: 12/31/1969
Washington Center for Bleeding Disorders at Bloodworks Northwest
mi
from
Seattle, WA
Click here to add this to my saved trials
QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
QUILT-3.034: Multi-Center Trial of Non-Myeloablative TCRa/b Deplete Haploidentical Hematopoietic Cell Transplantation With Post HCT ALT-803 in High-Risk Myeloid Diseases
Status: Enrolling
Updated:  12/31/1969
Masonic Cancer Center
mi
from
Minneapolis, MN
QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
QUILT-3.034: Multi-Center Trial of Non-Myeloablative TCRa/b Deplete Haploidentical Hematopoietic Cell Transplantation With Post HCT ALT-803 in High-Risk Myeloid Diseases
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Jacksonville Florida
mi
from
Jacksonville, FL
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Jacksonville Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
Northside Hospital
mi
from
Atlanta, GA
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Miami, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Miami, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Tamarac, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Tamarac, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Tampa, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
New Orleans, LA
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Toledo, OH
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Austin, TX
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Austin, TX
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Aurora, CO
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Jacksonville, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Detroit, MI
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Englewood, NJ
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Englewood, NJ
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Bethlehem, PA
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Little Rock, AR
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Coronado, CA
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Coronado, CA
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Pensacola, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Sarasota, FL
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Baltimore, MD
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Saint Louis, MO
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Reno, NV
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Reno, NV
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Buffalo, NY
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Durham, NC
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Durham, NC
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Winston-Salem, NC
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Study Site
mi
from
Milwaukee, WI
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Study Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Study Site
mi
from
Boston, MA
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Study Site
mi
from
Boston, MA
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Springfield, MO
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Springfield, MO
Click here to add this to my saved trials
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated:  12/31/1969
Dova Site
mi
from
Newport News, VA
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Status: Enrolling
Updated: 12/31/1969
Dova Site
mi
from
Newport News, VA
Click here to add this to my saved trials
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma
A Phase II Study of MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Patients With Newly Diagnosed Poor-risk or Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma
A Phase II Study of MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Patients With Newly Diagnosed Poor-risk or Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital
mi
from
Cleveland, OH
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
A Phase 2, Open-Label, Multiple Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Female Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
A Phase 2, Open-Label, Multiple Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Female Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
A Phase 2, Open-Label, Multiple Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Female Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Parkville,
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
A Phase 2, Open-Label, Multiple Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Female Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Parkville,
Click here to add this to my saved trials
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Hematologic Malignancies
Infusion of Off the Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells (NLA101) in the Setting of Single Cord Blood Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Hematologic Malignancies
Infusion of Off the Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells (NLA101) in the Setting of Single Cord Blood Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials